Of mice, men and nanoparticle biocoronas: arein vitrotoin vivocorrelations and interspecies extrapolations realistic?

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

(2013) Anna Salvati et al.   Nature Nanotechnology

Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance Equations

(2013) Faryad Darabi Sahneh et al.   PLoS One

Protein binding modulates the cellular uptake of silver nanoparticles into human cells: Implications for in vitro to in vivo extrapolations?

(2013) Nancy A. Monteiro-Riviere et al.   TOXICOLOGY LETTERS

Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells

(2012) Anna Lesniak et al.   ACS Nano

Biomolecular coronas provide the biological identity of nanosized materials

(2012) Marco P. Monopoli et al.   Nature Nanotechnology

Physiologically Based Pharmacokinetic Modeling of Nanoparticles

(2010) Mingguang Li et al.   ACS Nano

Theoretical Versus Empirical Allometry: Facts Behind Theories Application to Pharmacokinetics

(2010) Iftekhar Mahmood   JOURNAL OF PHARMACEUTICAL SCIENCES

Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid

(2010) Daniele Dell'Orco et al.   PLoS One

Comparison of Quantum Dot Biodistribution with a Blood-Flow-Limited Physiologically Based Pharmacokinetic Model

(2009) Hyun A. Lee et al.   NANO LETTERS

Understanding biophysicochemical interactions at the nano–bio interface

(2009) Andre E. Nel et al.   NATURE MATERIALS

Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots

(2008) Jim E. Riviere   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology